Variational AI, developer of the Enki™ generative artificial intelligence (AI) platform for drug discovery, announced a project with MSD (tradename of Merck & Co., Inc., Rahway, N.J., USA) supported by the CQDM Quantum Leap program to design novel and selective small molecules.